NEW YORK (GenomeWeb) – Caris Life Science said today that it will use informatics solutions offered by GenoSpace to support its oncology profiling services.

Specifically, Caris said it will use GenoSpace's population analytics offerings to analyze data from its tumor profiling service, Caris Molecular Intelligence. Caris will also leverage GenoSpace's analytics architecture expertise to mine data in Caris Registry, its database of clinicopathologic and outcome variables collected from consenting patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.